Literature DB >> 15657042

Atomic force microscopy imaging demonstrates that P2X2 receptors are trimers but that P2X6 receptor subunits do not oligomerize.

Nelson P Barrera1, Susan J Ormond, Robert M Henderson, Ruth D Murrell-Lagnado, J Michael Edwardson.   

Abstract

P2X receptors are cation-selective channels activated by extracellular ATP. The architecture of these receptors is still not completely clear. Here we have addressed this issue by both chemical cross-linking and direct imaging of individual receptors by atomic force microscopy (AFM). Cross-linking of the P2X(2) receptor produced higher order adducts, consistent with the presence of trimers. The mean molecular volume of the receptor determined by AFM (409 nm(3)) also points to a trimeric structure. P2X(2) receptors bearing His(6) epitope tags were incubated with anti-His(6) antibodies, and the resultant complexes were imaged by AFM. For receptors with two bound antibodies, the mean angle between the antibodies was 123 degrees , again indicating that the receptor is a trimer. In contrast, cross-linking of the P2X(6) receptor did not produce higher order adducts, and the mean molecular volume of the receptor was 145 nm(3). We conclude that P2X(2) receptors are trimers, whereas the P2X(6) receptor subunits do not form stable oligomers.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15657042     DOI: 10.1074/jbc.M412265200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  80 in total

Review 1.  Molecular and functional properties of P2X receptors--recent progress and persisting challenges.

Authors:  Karina Kaczmarek-Hájek; Eva Lörinczi; Ralf Hausmann; Annette Nicke
Journal:  Purinergic Signal       Date:  2012-05-01       Impact factor: 3.765

2.  The Kv7.2/Kv7.3 heterotetramer assembles with a random subunit arrangement.

Authors:  Andrew P Stewart; Juan Camilo Gómez-Posada; Jessica McGeorge; Maral J Rouhani; Alvaro Villarroel; Ruth D Murrell-Lagnado; J Michael Edwardson
Journal:  J Biol Chem       Date:  2012-02-13       Impact factor: 5.157

3.  Demonstration of a direct interaction between sigma-1 receptors and acid-sensing ion channels.

Authors:  Stewart M Carnally; Molly Johannessen; Robert M Henderson; Meyer B Jackson; J Michael Edwardson
Journal:  Biophys J       Date:  2010-04-07       Impact factor: 4.033

4.  Allosteric nature of P2X receptor activation probed by photoaffinity labelling.

Authors:  Y Bhargava; J Rettinger; A Mourot
Journal:  Br J Pharmacol       Date:  2012-11       Impact factor: 8.739

Review 5.  Insights into the channel gating of P2X receptors from structures, dynamics and small molecules.

Authors:  Jin Wang; Ye Yu
Journal:  Acta Pharmacol Sin       Date:  2016-01       Impact factor: 6.150

6.  P2X receptor intermediate activation states have altered nucleotide selectivity.

Authors:  Liam E Browne; R Alan North
Journal:  J Neurosci       Date:  2013-09-11       Impact factor: 6.167

Review 7.  Pharmacology of P2X channels.

Authors:  Joel R Gever; Debra A Cockayne; Michael P Dillon; Geoffrey Burnstock; Anthony P D W Ford
Journal:  Pflugers Arch       Date:  2006-04-29       Impact factor: 3.657

Review 8.  Purinergic transmission in the central nervous system.

Authors:  R Alan North; Alexei Verkhratsky
Journal:  Pflugers Arch       Date:  2006-05-11       Impact factor: 3.657

Review 9.  Determination of the architecture of ionotropic receptors using AFM imaging.

Authors:  Nelson P Barrera; Robert M Henderson; J Michael Edwardson
Journal:  Pflugers Arch       Date:  2007-11-17       Impact factor: 3.657

10.  Oligomerization of the microtubule-associated protein tau is mediated by its N-terminal sequences: implications for normal and pathological tau action.

Authors:  H Eric Feinstein; Sarah J Benbow; Nichole E LaPointe; Nirav Patel; Srinivasan Ramachandran; Thanh D Do; Michelle R Gaylord; Noelle E Huskey; Nicolette Dressler; Megan Korff; Brady Quon; Kristi Lazar Cantrell; Michael T Bowers; Ratnesh Lal; Stuart C Feinstein
Journal:  J Neurochem       Date:  2016-04-20       Impact factor: 5.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.